Week 7 Final Exam: NR546 NR-546

Week 7 Final Exam: NR546 / NR-546

(Latest Update 2025 / 2026) Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner | Questions and Answers | 100% Correct | Grade A - Chamberlain

Question:

Norepinephrine Dopamine Reuptake Inhibitor bupropion (Wellbutrin)

Answer:

off-label use for ADHD in adults

appropriate for clients with concurrent depression or tobacco abuse

• / 2

Question:

Prescribing Pearls: Non-stimulants

Answer:

no potential for abuse or diversion.effective for the long-term treatment of comorbid anxiety, depression, or substance abuse.Selection is based on therapeutic and adverse effects.special attention to cardiovascular, hepatic, neurological, and renal findings.Use when clients are too young for stimulants but need medication, intolerant of or have contraindications for stimulants have a client history of dependency or drug abuse or lack of response to stimulants alone.Monitor for abrupt behavior changes, suicidal ideation or self-harm, aggression, seizures, prolonged QT interval, increased peripheral vascular resistance, heart rate, and blood pressure.Concurrent use is contraindicated with MAO inhibitors (within the past 14 days), glaucoma, a history of pheochromocytoma, and cardiac or vascular disorders.Non-stimulant medications may exacerbate depression in clients with a history of the disorder.Non-stimulant medications can take longer to achieve desired effects than stimulants.Withdrawal needs to be tapered to prevent rebound hypertension and neurological side effects.increase GABA's inhibitory activity, leading to the decreased output of excitatory neurotransmitters resulting in the adverse effects related to BZO use.

• / 2